N-(2-하이드록시프로필)메타크릴아미드
N-(2-하이드록시프로필)메타크릴아미드 · DK667 · DK668 · DKFELEX0166 · 2-Hydroxypropyl methacrylamide · N-(2-HYDROXYPROPYL)METHACRYLAMID · N-(2-Hydroxypropyl)methacrylamide · N-(2-Hydroxypropyl)methacrylamide,98%

식별자 및 물리적 특성
| CAS No. | 21442-01-3 |
|---|---|
| 분자식 | C7H13NO2 |
| 평균 분자량 | 143.18 g/mol |
| 단동위원소 질량 | 143.09462866 g/mol |
| SMILES | C=C(C)C(=O)NCC(C)O |
| InChIKey | OKPYIWASQZGASP-UHFFFAOYSA-N |
| PubChem CID | 38622 |
| EC No. | 801-057-1 |
| DTXSID | DTXSID30944024 |
| 현지명 | N-(2-하이드록시프로필)메타크릴아미드 |
화학 및 물리적 성질
| XLogP | 0.3 |
|---|---|
| 극성 표면적 | 49.3 |
| 수소 결합 공여자 수 | 2 |
| 수소 결합 수용자 수 | 2 |
| 회전 가능 결합 수 | 3 |
| 무거운 원자 수 | 10 |
| 형식 전하 | 0 |
| 복잡도 | 143 |
| 녹는점 | 67.92°C |
| 끓는 점 | 321.2±34.0 °C(Predicted) |
| 밀도 | 1.002 g/mL ((predicted)) |
| 저장 조건 | 2-8°C |
| 용해도 | DMSO에 용해됨 |
| pKa(산도 계수) | 14.43±0.20(Predicted) |
| 물리적 상태 | 가루 |
| 색상 | White to off-white |
| InChI | 1S/C7H13NO2/c1-5(2)7(10)8-4-6(3)9/h6,9H,1,4H2,2-3H3,(H,8,10) |
| InChIKey | OKPYIWASQZGASP-UHFFFAOYSA-N |
| SMILES | CC(O)CNC(=O)C(C)=C |
안전 및 규제
| GHS 분류 | WarningH315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. |
|---|---|
| 수질 위해 등급(WGK) | 3 |
| 관세 코드 | 2924297099 |
| 위험 문구(R) | 36/37/38 |
| 안전 문구(S) | 26-36/37/39 |
| 저장 분류 | 11 - Combustible Solids |
용도
개요
N-(2-hydroxypropyl)methacrylamide (HPMA) is an important hydrophilic monomer. Due to the non-toxic, non-immunogenic properties and prolonged circulation time of both its homopolymers and copolymers, it is widely employed in the preparation of PHPMA copolymers (a polymer-drug conjugate) for use in the biopharmaceutical industry. For instance, poly(HPMA-co-MA-GFLG-doxorubicin) represents the first intravenous tumour-targeting polymeric prodrug to enter clinical trials. HPMA polymers and copolymers are also employed in the fabrication of biocompatible medical materials such as hydrogels[1].
용도
Monomers to synthesize biocompetible polymers and copolymers for drug carriers, protein conjugates and hydrogels in biomedical applications.